Literature DB >> 33234343

Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.

Om P S Patel1, Omobolanle Janet Jesumoroti2, Lesetja J Legoabe3, Richard M Beteck2.   

Abstract

Nitroimidazoles based compounds remain a hot topic of research in medicinal chemistry due to their numerous biological activities. Moreover, many clinical candidates based on this chemical core have been reported to be valuable in the treatment of human diseases. Metronidazole (MTZ) derived conjugates demonstrated a potential application in medicinal chemistry research over the last decade. In this review, we summarize the synthesis, key structure-activity-relationship (SAR) and associated biological activities such as antimicrobial, anticancer, antidiabetic, anti-inflammatory, anti-HIV and anti-parasitic (Anti-trichomonas, antileishmanial, antiamoebic and anti-giardial) of explored MTZ-conjugates. The molecular docking analysis is also presented simultaneously, which will assist in developing an understanding towards designing of new MTZ-conjugates for target-based drug discovery against multiple disease areas.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Biological activities; Metronidazole-conjugates; Molecular docking study; Nitroimidazole; Structure-activity relationship (SAR); Synthesis

Mesh:

Substances:

Year:  2020        PMID: 33234343     DOI: 10.1016/j.ejmech.2020.112994

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Thio- and selenosemicarbazones as antiprotozoal agents against Trypanosoma cruzi and Trichomonas vaginalis.

Authors:  Alexandra Ibáñez-Escribano; Cristina Fonseca-Berzal; Mónica Martínez-Montiel; Manuel Álvarez-Márquez; María Gómez-Núñez; Manuel Lacueva-Arnedo; Teresa Espinosa-Buitrago; Tania Martín-Pérez; José Antonio Escario; Penélope Merino-Montiel; Sara Montiel-Smith; Alicia Gómez-Barrio; Óscar López; José G Fernández-Bolaños
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

2.  Recurrent neural network (RNN) model accelerates the development of antibacterial metronidazole derivatives.

Authors:  Nannan Chen; Lijuan Yang; Na Ding; Guiwen Li; Jiajing Cai; Xiaoli An; Zhijie Wang; Jie Qin; Yuzhen Niu
Journal:  RSC Adv       Date:  2022-08-15       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.